1,9-dideoxyforskolin has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
Studies (1,9-dideoxyforskolin) | Trials (1,9-dideoxyforskolin) | Recent Studies (post-2010) (1,9-dideoxyforskolin) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
---|---|---|---|---|---|
111 | 0 | 2 | 1,301 | 1 | 165 |
Protein | Taxonomy | 1,9-dideoxyforskolin (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gean, PW; Huang, CC | 1 |
1 other study(ies) available for 1,9-dideoxyforskolin and 1,3-dipropyl-8-cyclopentylxanthine
Article | Year |
---|---|
Cyclic adenosine-3',5'-monophosphate potentiates the synaptic potential mediated by NMDA receptors in the amygdala.
Topics: Amygdala; Animals; Bucladesine; Colforsin; Cyclic AMP; Electric Stimulation; Long-Term Potentiation; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Xanthines | 1995 |